Lehrstuhl für Pharmazeutische Chemie

Development and Initial Characterization of the First 18F-CXCR2-Targeting Radiotracer for PET Imaging of Neutrophils (2024) Spatz P, Chen X, Reichau K, Huber M, Mühlig S, Matsusaka Y, Schiedel M, et al. Journal article Structural and functional characterization of the endogenous agonist for orphan receptor GPR3 (2024) Chen G, Staffen N, Wu Z, Xu X, Pan J, Inoue A, Shi T, et al. Journal article, Letter Visible light-mediated catalyst-free radical arylations using arenediazonium salts (2024) Wenisch P, Kuschow M, Heinrich M Journal article, Review article “Photo-Adrenalines”: Photoswitchable β2-Adrenergic Receptor Agonists as Molecular Probes for the Study of Spatiotemporal Adrenergic Signaling (2024) Sink A, Gerwe H, Hübner H, Boivin-Jahns V, Fender J, Lorenz K, Gmeiner P, Decker M Journal article Oriented display of HIV-1 Env trimers by a novel coupling strategy enhances B cell activation and phagocytosis (2024) Di Vincenzo R, Beutel J, Arnold P, Wang Y, Damm D, Tannig P, Lux A, et al. Journal article Illuminating Neuropeptide Y Y4 Receptor Binding: Fluorescent Cyclic Peptides with Subnanomolar Binding Affinity as Novel Molecular Tools (2024) Gleixner J, Kopanchuk S, Grätz L, Tahk MJ, Laasfeld T, Veikšina S, Höring C, et al. Journal article Author Correction: Constrained catecholamines gain β2AR selectivity through allosteric effects on pocket dynamics (Nature Communications, (2023), 14, 1, (2138), 10.1038/s41467-023-37808-y) (2023) Xu X, Shonberg J, Kaindl J, Clark MJ, Stößel A, Maul L, Mayer D, et al. Journal article, Erratum Constrained catecholamines gain β2AR selectivity through allosteric effects on pocket dynamics (2023) Xu X, Shonberg J, Kaindl J, Clark MJ, Stößel A, Maul L, Mayer D, et al. Journal article Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor (2023) Xu J, Wang Q, Hübner H, Hu Y, Niu X, Wang H, Maeda S, et al. Journal article Development of Photoswitchable Tethered Ligands that Target the μ-Opioid Receptor (2023) Lahmy R, Hübner H, Lachmann D, Gmeiner P, König B Journal article